Literature DB >> 18722380

Nitric oxide signaling and the regulation of myocardial function.

Mark T Ziolo1, Mark J Kohr, Honglan Wang.   

Abstract

Nitric oxide, which is produced endogenously within cardiac myocytes by three distinct isoforms of nitric oxide synthase, is a key regulator of myocardial function. This review will focus on the regulation of myocardial function by each nitric oxide synthase isoform during health and disease, with a specific emphasis on the proposed end-targets and signaling pathways.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18722380      PMCID： PMC3282562          DOI： 10.1016/j.yjmcc.2008.07.015

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


  116 in total

1.  When is cAMP not cAMP? Effects of compartmentalization.

Authors:  D M Bers; M T Ziolo
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

Review 2.  Nitrosylation. the prototypic redox-based signaling mechanism.

Authors:  J S Stamler; S Lamas; F C Fang
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

3.  Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes.

Authors:  M G Petroff; S H Kim; S Pepe; C Dessy; E Marbán; J L Balligand; S J Sollott
Journal:  Nat Cell Biol       Date:  2001-10       Impact factor: 28.824

4.  Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes.

Authors:  M O Stojanovic; M T Ziolo; G M Wahler; B M Wolska
Journal:  Am J Physiol Cell Physiol       Date:  2001-07       Impact factor: 4.249

5.  Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.

Authors:  F Brunner; P Andrew; G Wölkart; R Zechner; B Mayer
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

6.  Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes.

Authors:  M T Ziolo; H Katoh; D M Bers
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

Review 7.  Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

8.  Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current.

Authors:  M T Ziolo; C H Harshbarger; K E Roycroft; J M Smith; F D Romano; K L Sondgeroth; G M Wahler
Journal:  J Mol Cell Cardiol       Date:  2001-09       Impact factor: 5.000

9.  Positive and negative effects of nitric oxide on Ca(2+) sparks: influence of beta-adrenergic stimulation.

Authors:  M T Ziolo; H Katoh; D M Bers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-12       Impact factor: 4.733

10.  In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice.

Authors:  A Rakhit; C T Maguire; H Wakimoto; J Gehrmann; G K Li; R A Kelly; T Michel; C I Berul
Journal:  J Cardiovasc Electrophysiol       Date:  2001-11
View more
  56 in total

1.  Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17β-estradiol and the environmental endocrine disruptor bisphenol A.

Authors:  Scott M Belcher; Yamei Chen; Sujuan Yan; Hong-Sheng Wang
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

Review 2.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 3.  Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.

Authors:  Weiwei Li; Brian Olshansky
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

4.  Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation.

Authors:  Honglan Wang; Serge Viatchenko-Karpinski; Junhui Sun; Inna Györke; Nancy A Benkusky; Mark J Kohr; Héctor H Valdivia; Elizabeth Murphy; Sandor Györke; Mark T Ziolo
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

5.  A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium.

Authors:  Amit A Doshi; Mark T Ziolo; Honglan Wang; Emily Burke; Amanda Lesinski; Philip Binkley
Journal:  J Card Fail       Date:  2010-02-07       Impact factor: 5.712

Review 6.  Cardioprotective actions of cyclic GMP: lessons from genetic animal models.

Authors:  Christian F Deschepper
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

7.  cAMP-independent activation of protein kinase A by the peroxynitrite generator SIN-1 elicits positive inotropic effects in cardiomyocytes.

Authors:  Mark J Kohr; Christopher J Traynham; Steve R Roof; Jonathan P Davis; Mark T Ziolo
Journal:  J Mol Cell Cardiol       Date:  2010-01-18       Impact factor: 5.000

8.  Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction.

Authors:  Gad A Silberman; Tai-Hwang M Fan; Hong Liu; Zhe Jiao; Hong D Xiao; Joshua D Lovelock; Beth M Boulden; Julian Widder; Scott Fredd; Kenneth E Bernstein; Beata M Wolska; Sergey Dikalov; David G Harrison; Samuel C Dudley
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

9.  Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties.

Authors:  Euy-Myoung Jeong; Michelle M Monasky; Lianzhi Gu; Domenico M Taglieri; Bindiya G Patel; Hong Liu; Qiongying Wang; Ian Greener; Samuel C Dudley; R John Solaro
Journal:  J Mol Cell Cardiol       Date:  2012-12-14       Impact factor: 5.000

10.  Depressed calcium-handling proteins due to endoplasmic reticulum stress and apoptosis in the diabetic heart are attenuated by argirein.

Authors:  F H Shi; Y S Cheng; D Z Dai; H J Peng; X D Cong; Y Dai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-24       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.